Meeder Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-160
| Closed | -$14.5K | – | 1062 |
|
|
2026
Q1 | $14.5K | Buy |
160
+100
| +167% | +$9.18K | ﹤0.01% | 632 |
|
|
2025
Q4 | $5.39K | Buy |
60
+5
| +9% | +$474 | ﹤0.01% | 787 |
|
|
2025
Q3 | $5.42K | Sell |
55
-1
| -2% | -$99 | ﹤0.01% | 654 |
|
|
2025
Q2 | $5.11K | Buy |
+56
| New | +$5.42K | ﹤0.01% | 718 |
|
|
2025
Q1 | – | Sell |
-76
| Closed | -$8.03K | – | 1068 |
|
|
2024
Q4 | $8.03K | Buy |
+76
| New | +$8.15K | ﹤0.01% | 749 |
|
|
2024
Q3 | – | Sell |
-77
| Closed | -$8.36K | – | 973 |
|
|
2024
Q2 | $8.36K | Buy |
+77
| New | +$9.08K | ﹤0.01% | 687 |
|
|
2023
Q3 | – | Sell |
-25,470
| Closed | -$3.71M | – | 598 |
|
|
2023
Q2 | $3.71M | Buy |
25,470
+23,663
| +1,310% | +$3.22M | 0.27% | 84 |
|
|
2023
Q1 | $233K | Sell |
1,807
-299
| -14% | -$37.5K | 0.02% | 281 |
|
|
2022
Q4 | $269K | Sell |
2,106
-7,575
| -78% | -$879K | 0.02% | 327 |
|
|
2022
Q3 | $1.01M | Buy |
9,681
+7,043
| +267% | +$773K | 0.06% | 243 |
|
|
2022
Q2 | $277K | Sell |
2,638
-333
| -11% | -$39.5K | 0.02% | 534 |
|
|
2022
Q1 | $380K | Buy |
2,971
+265
| +10% | +$31.9K | 0.02% | 483 |
|
|
2021
Q4 | $334K | Buy |
2,706
+67
| +3% | +$8.77K | 0.03% | 256 |
|
|
2021
Q3 | $375K | Sell |
2,639
-16,766
| -86% | -$2.47M | 0.02% | 538 |
|
|
2021
Q2 | $3.03M | Sell |
19,405
-6,208
| -24% | -$1.01M | 0.14% | 129 |
|
|
2021
Q1 | $3.98M | Buy |
25,613
+24,100
| +1,593% | +$3.73M | 0.2% | 105 |
|
|
2020
Q4 | $226K | Sell |
1,513
-11,388
| -88% | -$1.61M | 0.05% | 289 |
|
|
2020
Q3 | $1.71M | Sell |
12,901
-5,911
| -31% | -$772K | 0.11% | 153 |
|
|
2020
Q2 | $2.18M | Sell |
18,812
-24,805
| -57% | -$2.86M | 0.14% | 128 |
|
|
2020
Q1 | $4.28M | Buy |
43,617
+3,621
| +9% | +$475K | 0.33% | 64 |
|
|
2019
Q4 | $5.81M | Buy |
39,996
+1,944
| +5% | +$268K | 0.36% | 75 |
|
|
2019
Q3 | $5.07M | Buy |
38,052
+21,693
| +133% | +$2.8M | 0.34% | 83 |
|
|
2019
Q2 | $1.87M | Buy |
16,359
+2,298
| +16% | +$269K | 0.13% | 139 |
|
|
2019
Q1 | $1.74M | Buy |
14,061
+1,219
| +9% | +$139K | 0.14% | 138 |
|
|
2018
Q4 | $1.29M | Sell |
12,842
-16,106
| -56% | -$1.81M | 0.12% | 162 |
|
|
2018
Q3 | $3.7M | Buy |
28,948
+27,688
| +2,197% | +$3.29M | 0.28% | 92 |
|
|
2018
Q2 | $136K | Sell |
1,260
-10,754
| -90% | -$1.17M | 0.01% | 572 |
|
|
2018
Q1 | $1.27M | Buy |
+12,014
| New | +$1.4M | 0.12% | 169 |
|
|
2016
Q4 | – | Sell |
-1,746
| Closed | -$220K | – | 1077 |
|
|
2016
Q3 | $220K | Sell |
1,746
-4,479
| -72% | -$553K | 0.02% | 532 |
|
|
2016
Q2 | $728K | Buy |
+6,225
| New | +$705K | 0.07% | 297 |
|
|
2014
Q3 | – | Sell |
-9,697
| Closed | -$978K | – | 396 |
|
|
2014
Q2 | $978K | Sell |
9,697
-20,065
| -67% | -$1.96M | 0.15% | 119 |
|
|
2014
Q1 | $2.73M | Buy |
+29,762
| New | +$2.74M | 0.45% | 69 |
|
|
2013
Q3 | – | Sell |
-22,238
| Closed | -$1.62M | – | 389 |
|
|
2013
Q2 | $1.62M | Buy |
+22,238
| New | +$1.66M | 0.32% | 87 |
|
Other funds holding ZBH
Meeder Asset Management's ZBH Position: Q2 2026 in Review
Meeder Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 160 shares — an estimated $14.5K sold.
Meeder Asset Management first reported a position in ZBH in Q2 2013 and held it in 33 quarters. The position peaked at $5.81M in Q4 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Meeder Asset Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
- Meeder Asset Management sold 160 Zimmer Biomet shares in Q2 2026, an estimated $14.5K.
- Meeder Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 33 quarters.
- Meeder Asset Management's Zimmer Biomet position peaked at $5.81M in Q4 2019.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.